Advertising

Medical Facilities Corp.

DR-T

Analysis and Opinions about DR-T

Signal
Opinion
Expert
Chart
TOP PICK
TOP PICK
August 25, 2021
They provide elective surgical services in the U.S., though it's a Canadian company. Because of Covid, those services have collapsed, but will recover as the economy reopens. Such surgical demand will be out of sight, because of huge pent-up demand. Also, the valuation is much lower than the historic norm. They will enjoy 2-3 boom years. (Analysts’ price target is $9.84)
Show full opinionHide full opinion
They provide elective surgical services in the U.S., though it's a Canadian company. Because of Covid, those services have collapsed, but will recover as the economy reopens. Such surgical demand will be out of sight, because of huge pent-up demand. Also, the valuation is much lower than the historic norm. They will enjoy 2-3 boom years. (Analysts’ price target is $9.84)
Ross Healy
Price
$9.480
Owned
Yes
BUY
BUY
May 20, 2021
Owns it in income growth. Dividend halted with the pandemic. Non-necessary medical procedures were delayed, and now they're coming back rapidly. Dividend will be restored. Stock should at least get north of $10.
Show full opinionHide full opinion
Owns it in income growth. Dividend halted with the pandemic. Non-necessary medical procedures were delayed, and now they're coming back rapidly. Dividend will be restored. Stock should at least get north of $10.
Bruce Murray
Price
$7.290
Owned
Yes
HOLD
HOLD
April 26, 2021
They own ambulatory facilities in the US. There was concern about how soon they could get their surgeries up and running again after COVID. There are issues around Medicare and Medicaid paying for procedures. These are always a risk. He still owns it. It seems like things are continuing to improve. You could at least get the recovery, although the long term growth is not what it was previously.
Show full opinionHide full opinion
They own ambulatory facilities in the US. There was concern about how soon they could get their surgeries up and running again after COVID. There are issues around Medicare and Medicaid paying for procedures. These are always a risk. He still owns it. It seems like things are continuing to improve. You could at least get the recovery, although the long term growth is not what it was previously.
Jamie Murray
Price
$7.330
Owned
Yes
BUY
BUY
August 24, 2020
It's a real estate play on medical facilities in the US. It was overleveraged a few years ago, then COVID declined their business, which are non-essential surgeries. But they're still profitable and paying dividends. He sees upside.
Show full opinionHide full opinion
It's a real estate play on medical facilities in the US. It was overleveraged a few years ago, then COVID declined their business, which are non-essential surgeries. But they're still profitable and paying dividends. He sees upside.
Bruce Murray
Price
$4.360
Owned
Yes
SELL
SELL
February 24, 2020
He is always very suspicious of a company with all of its assets in the US that lists on a Canadian exchange. Medical facilities in the US are a different market from the Canadian one. We've seen similar companies in the US where it didn't end well.
Show full opinionHide full opinion
He is always very suspicious of a company with all of its assets in the US that lists on a Canadian exchange. Medical facilities in the US are a different market from the Canadian one. We've seen similar companies in the US where it didn't end well.
DON'T BUY
DON'T BUY
January 23, 2020
They have surgical facilities in the US. It was trading for the dividend and then things fell off the rails and they cut the dividend. He was concerned that something was wrong. They made an asset sale recently to try to clean things up. Let the shareholder base switch over and let things settle.
Show full opinionHide full opinion
They have surgical facilities in the US. It was trading for the dividend and then things fell off the rails and they cut the dividend. He was concerned that something was wrong. They made an asset sale recently to try to clean things up. Let the shareholder base switch over and let things settle.
Peter Hodson
Price
$4.610
Owned
Unknown
COMMENT
COMMENT
January 2, 2020
He owned it because of the big dividend yield. Management was always optimistic about the hospital being built in South Dakota and thought because they had a lot of other facilities it might mitigate the situation. They told us the last two quarters that everything was fine but now we find it is not.
Show full opinionHide full opinion
He owned it because of the big dividend yield. Management was always optimistic about the hospital being built in South Dakota and thought because they had a lot of other facilities it might mitigate the situation. They told us the last two quarters that everything was fine but now we find it is not.
Bruce Murray
Price
$4.800
Owned
Yes
DON'T BUY
DON'T BUY
December 31, 2019
A classic avoid stock. The chart has plummeted this year. The trendline (past low) was taken out with several breakdowns and consolidations (several drops).
Show full opinionHide full opinion
A classic avoid stock. The chart has plummeted this year. The trendline (past low) was taken out with several breakdowns and consolidations (several drops).
DON'T BUY
DON'T BUY
December 30, 2019
Medical facilities. He has been short the stock. They have facilities in North Dakota. Another group of doctors opened up their own facilities down the street. He is not sure how safe the dividend is.
Show full opinionHide full opinion
Medical facilities. He has been short the stock. They have facilities in North Dakota. Another group of doctors opened up their own facilities down the street. He is not sure how safe the dividend is.
James Hodgins
Price
$4.720
Owned
Unknown
WAIT
WAIT
November 28, 2019
Three quarters in a row of disappointing results. Made a very dramatic dividend cut. Yield is now around 4%. Stock is bouncing in the $4-5 range. Owns medical building in the States. Debt to equity ratio is not too severe. Suspects they will be able to paydown debt now. Disappointing story but continues to hold it. Hasn't decided to buy more yet. Would like to see a couple more quarters and see if the business stabilizes.
Show full opinionHide full opinion
Three quarters in a row of disappointing results. Made a very dramatic dividend cut. Yield is now around 4%. Stock is bouncing in the $4-5 range. Owns medical building in the States. Debt to equity ratio is not too severe. Suspects they will be able to paydown debt now. Disappointing story but continues to hold it. Hasn't decided to buy more yet. Would like to see a couple more quarters and see if the business stabilizes.
Bruce Murray
Price
$4.730
Owned
Yes
DON'T BUY
DON'T BUY
November 1, 2019
He has had grief with this over the years. It only trades at 13 times earnings and a great yield but a payout ratio of 167%. It has missed earnings. Although it is cheap, it does not have good price momentum. Yield 14%
Show full opinionHide full opinion
He has had grief with this over the years. It only trades at 13 times earnings and a great yield but a payout ratio of 167%. It has missed earnings. Although it is cheap, it does not have good price momentum. Yield 14%
Jason Mann
Price
$7.820
Owned
No
DON'T BUY
DON'T BUY
September 19, 2019
He doesn't cover it, but DR had a disastrous quarter and the wheels came off. He doesn't understand the reason why. He's scared of it. Also, their debt is high. Pays a 14% dividend which likely isn't safe.
Show full opinionHide full opinion
He doesn't cover it, but DR had a disastrous quarter and the wheels came off. He doesn't understand the reason why. He's scared of it. Also, their debt is high. Pays a 14% dividend which likely isn't safe.
Peter Hodson
Price
$7.990
Owned
No
HOLD
HOLD
September 16, 2019
They have a strong balance. The dividend is fine. But the issues revolve around their clinics. A new public hospital has stolen some business in South Dakota, and DR had two quarters. He averaged down this year and comfortable to hold it. But he'll keep an eye on the next quarter.
Show full opinionHide full opinion
They have a strong balance. The dividend is fine. But the issues revolve around their clinics. A new public hospital has stolen some business in South Dakota, and DR had two quarters. He averaged down this year and comfortable to hold it. But he'll keep an eye on the next quarter.
Bruce Murray
Price
$8.030
Owned
Yes
BUY
BUY
July 30, 2019
He owns this and tries to buy it under $14 and selling over $16, while collecting a fat dividend. Their recent earnings were less profitable and the company says things will improve going forward. In South Dakota there could be competitive pressure as a large hospital facility has been built. He thinks there is no end of demand for users. He would buy here.
Show full opinionHide full opinion
He owns this and tries to buy it under $14 and selling over $16, while collecting a fat dividend. Their recent earnings were less profitable and the company says things will improve going forward. In South Dakota there could be competitive pressure as a large hospital facility has been built. He thinks there is no end of demand for users. He would buy here.
Bruce Murray
Price
$12.550
Owned
Yes
DON'T BUY
DON'T BUY
July 26, 2019
Did they raise the dividend just to keep investors interested, and is that 9.28% yield stable? Their payout ratio is beyond 100%, a concern. He has owned this in the past. They missed earnings. Decent valuation at 5x EBITDA and cash flow. Balance sheet is okay. They might be able to maintain that dividend. The stock price is a challenge--can it rise? And they need a highly valued stock in order to be a growth-by-acqusition stock. (He isn't aware of a dividend increase, though.)
Show full opinionHide full opinion
Did they raise the dividend just to keep investors interested, and is that 9.28% yield stable? Their payout ratio is beyond 100%, a concern. He has owned this in the past. They missed earnings. Decent valuation at 5x EBITDA and cash flow. Balance sheet is okay. They might be able to maintain that dividend. The stock price is a challenge--can it rise? And they need a highly valued stock in order to be a growth-by-acqusition stock. (He isn't aware of a dividend increase, though.)
Jason Mann
Price
$12.280
Owned
Unknown
Showing 1 to 15 of 78 entries

Medical Facilities Corp.(DR-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Medical Facilities Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Medical Facilities Corp.(DR-T) Frequently Asked Questions

What is Medical Facilities Corp. stock symbol?

Medical Facilities Corp. is a Canadian stock, trading under the symbol DR-T on the Toronto Stock Exchange (DR-CT). It is usually referred to as TSX:DR or DR-T

Is Medical Facilities Corp. a buy or a sell?

In the last year, 2 stock analysts published opinions about DR-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is TOP PICK. Read the latest stock experts' ratings for Medical Facilities Corp..

Is Medical Facilities Corp. a good investment or a top pick?

Medical Facilities Corp. was recommended as a Top Pick by Ross Healy on 2021-08-25. Read the latest stock experts ratings for Medical Facilities Corp..

Why is Medical Facilities Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Medical Facilities Corp. worth watching?

2 stock analysts on Stockchase covered Medical Facilities Corp. In the last year. It is a trending stock that is worth watching.

What is Medical Facilities Corp. stock price?

On 2021-09-20, Medical Facilities Corp. (DR-T) stock closed at a price of $9.36.